Krka DD (WAR:KRK) Notes Receivable: zł0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:KRK Krka DD WAR:KRK
93 GF Score
Price zł1,124.00
GF Value zł768.38
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Krka DD Notes Receivable?

Krka DD WAR:KRK -0.53% 93 Notes Receivable is zł0 Mil as of Jun. 2026. GuruFocus rates WAR:KRK with a GF Score™ of 93/100 and a GF Value™ of zł768.38 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Krka DD's Notes Receivable for the quarter that ended in Jun. 2026 was zł0 Mil.

Krka DD Notes Receivable Historical Data

* Premium members only.

The historical data trend for Krka DD's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Krka DD Notes Receivable Chart

Krka DD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Krka DD Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
WAR:KRK
93GF Score
Krka DD WAR:KRK
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Krka DD Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of zł0 Mil mean?
Krka DD (WAR:KRK) has a Notes Receivable of zł0 Mil as of Jun. 2026. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Krka DD and its competitors.
Is Krka DD's Notes Receivable too high?
Krka DD's current Notes Receivable is zł0 Mil. Overall, Krka DD has a GF Score™ of 93/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Krka DD's Notes Receivable compare to ZTS and UTHR?
Krka DD's Notes Receivable of zł0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Drug Manufacturers company?
A good Notes Receivable depends on the Drug Manufacturers industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Krka DD and its competitors. Krka DD's current Notes Receivable is zł0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Krka DD stock overvalued right now?
Based on GuruFocus' analysis, Krka DD (WAR:KRK) is currently considered Significantly Overvalued. The stock's GF Value™ is zł768.38, compared to a current price of zł1,124.00 — trading 46.3% above its estimated fair value. The current Notes Receivable is zł0 Mil. Krka DD's overall GF Score™ is 93/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Krka DD (WAR:KRK), the current Notes Receivable is zł0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Krka DD (WAR:KRK) Overvalued in 2026?

Based on GuruFocus' analysis, Krka DD stock appears to be overvalued. The current stock price of zł1,124.00 is trading 46.3% above its estimated GF Value™ of zł768.38. GuruFocus considers Krka DD to be Significantly Overvalued.

Key valuation signals for WAR:KRK:

  • Notes Receivable: zł0 Mil
  • GF Value™: zł768.38 vs. price of zł1,124.00 (46.3% above fair value)
  • GF Score™: 93/100 with 4 warning signs

No single metric tells the full story. See the WAR:KRK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Krka DD Business Description

Address Smarjeska Cesta 6, Novo Mesto, SVN, 8501
Krka DD engages in the development, production, marketing, and sales of human health products (prescription pharmaceuticals and non-prescription products), animal health products, health resorts, and tourist services. The company's products in Prescription pharmaceuticals include Cardiovascular diseases, Infections, and Oncology; Non-prescription products include Cold and cough products, nasal products, vitamins and minerals, and hair care products; and Animal health products include Antimicrobials and disinfectants, among others. It operates across the European Union, South-East Europe, Eastern Europe region, and Others. The company derives a majority of its revenue from the European Union.
93GF Score

Get the complete analysis for WAR:KRK

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł1,124.00
Price
zł768.38
GF Value